08/14/2015 - 12:03pm

Mylan announced will continue to urge its shareholders to vote in favor of its proposed acquisition of Perrigo despite Institutional Shareholder Services’ recommendation against the deal in a recent report.

08/14/2015 - 10:55am

The research project will provide pharmacogenomics services in community pharmacies including collection of DNA samples, interpretation of patient results, counseling and collaboration with prescribers. 

08/12/2015 - 2:21pm

Dr. Reddy’s Laboratories has announced the launch and FDA approval of its pramipexole dihydrochloride extended release tablets.

08/12/2015 - 1:01pm

Verde Technologies has announced a pilot program for its Deterra Drug Deactivation System that will see the company partner with the Delaware Prescription Action Committee (PDAC) and the Delaware Pharmacists Societyt to combat prescription drug abuse.

08/12/2015 - 10:00am

Testing on an edible on-dose authentication technology developed by TruTag Technologies is showing promising results for its use in combatting counterfeit drugs. 

08/11/2015 - 3:35pm

Three years after it launched its EpiPen4ASchools program, Mylan announced this week that it would continue through the 2015-2016 school year.

08/11/2015 - 1:20pm

The medication synchronization service allows patients to pick up all their medication in a monthly pharmacy visit and manage their prescriptions online. 

08/10/2015 - 10:39am

The company’s memantine hydrochloride tablets, available in 5- and 10-mg dosage strengths, are meant to treat dementia associated with Alzheimer’s disease.

08/10/2015 - 10:01am

The Food and Drug Administration approved Mylan's Lidocaine Patch 5%, a generic version of Endo Pharmaceutical's Lidoderm.